S. Setty et al., GLUCOSE-INDUCED ALTERATION OF INTEGRIN EXPRESSION AND FUNCTION IN CULTURED HUMAN MESANGIAL CELLS, Cell adhesion and communication, 3(3), 1995, pp. 187
Alteration in mesangial volume, due to an increase of the matrix surro
unding mesangial cells, is a hallmark indicator of nephropathy in diab
etes. Mesangial cells may also play a significant role in the developm
ent of nephropathy. Therefore, we examined the effect of glucose on th
e expression of integrins by cultured human mesangial cells and their
ability to interact with collagen IV, a major component of the mesangi
al matrix. Human mesangial cells were grown in 5 and 25 mM glucose and
their integrin profile was examined by immunoprecipitation and flow c
ytometry in each experimental condition. The results indicate that whe
n mesangial cells were grown in 25 mM glucose, the expression of integ
rin subunit alpha 2, was increased, while the alpha 1 subunit was cons
iderably decreased, as compared to cells grown in 5 mM glucose. Additi
onally, mesangial cells were tested for their ability to adhere to col
lagen IV in a solid-phase assay in the presence of neutralizing antibo
dies to integrin subunits. The results of these experiments indicate t
hat both alpha 1 and alpha 2 complexed to beta 1 (alpha 2 beta 1 and a
lpha 1 beta 1) are major mesangial cell receptors for adhesion to coll
agen IV both in 5 and 25 mM glucose. The two receptors act in concert
to mediate adhesion of mesangial cells to type IV collagen. When cell
surface expression of the alpha 1 subunit in 25 mM glucose was reduced
, the alpha 2 subunit was involved in adhesion to a greater extent tha
n it was in 5 mM glucose. Immunoperoxidase histochemical studies local
ized both al and alpha 2 integrin subunits in the mesangium of normal
adult kidneys, suggesting that in vivo interaction with collagen IV co
uld involve both of these receptors. These observations suggest that g
lucose-induced alterations in integrin expression may modify the abili
ty of mesangial cells to interact with collagen IV.